Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells

Kavas, Aysegul
Keskin, Dilek
Altunbas, Korhan
Tezcaner, Ayşen
Raloxifene (Ral)- or Ral-poly(ethylene glycol) (PEG) conjugate-loaded microspheres were prepared with poly(e-caprolactone) (PCL) alone or with the blend of PCL and poly(D,L-lactide-co-glycolide) (PLGA) to provide controlled and sustained Ral release systems. Benefits of these formulations were evaluated on bone regeneration. Ral-loaded PCL microspheres had the highest encapsulation efficiency (70.7 +/- 5.0%) among all groups owing to high hydrophobic natures of both Ral and PCL. Cumulative amount of Ral released from Ral-PEG (1: 2) conjugate-loaded PCL: PLGA (1: 1) microspheres (26.9 +/- 8.8%) after 60 days was significantly higher relative to other microsphere groups. This finding can be ascribed to two factors: i) Ral-PEG conjugation, resulting in increased water-solubility of Ral and increased degradation rates of PCL and PLGA with enhanced water penetration into the polymer matrix, and ii) usage of PLGA besides PCL in the carrier composition to benefit from less hydrophobic and faster degradable nature of PLGA in comparison to PCL. In vitro cytotoxicity studies performed using adipose-derived mesenchymal stem cells (ASCs) demonstrated that all microspheres were non-toxic. Evaluation of intensities of Alizarin red S staining conducted after 7 and 14 days of incubation of ASCs in the release media of the different microsphere groups was performed with Image J analysis software. At day 7, it was observed that the matrix deposited by the cells cultivated in the release medium of Ral-PEG (1: 2) conjugate-loaded PCL: PLGA (1: 1) microspheres had significantly higher mineral content (26.78 +/- 6.23%) than that of the matrix deposited by the cells cultivated in the release media of the other microsphere groups except Ral-loaded PCL: PLGA (1: 1) microsphere group. At day 14, Ral release from Ral-PEG (1: 2) conjugate-loaded PCL: PLGA (1: 1) microsphere group resulted with significantly higher mineralization of the matrix (32.31 +/- 1.85%) deposited by ASCs in comparison to all other microsphere groups. Alizarin red S staining results eventuated in parallel with the release results. Thus, it can be suggested that Ral-PEG (1: 2) conjugateloaded PCL: PLGA (1: 1) microsphere formulation has a potential as an effective controlled drug delivery system for bone regeneration. (C) 2016 Elsevier B. V. All rights reserved.


Pyrolysis of poly(phenylene vinylene)s with polycaprolactone side chains
Nur, Yusuf; Çolak, Demet; Cianga, Ioan; Yagci, Yusuf; Hacaloğlu, Jale (2008-05-01)
The thermal degradation characteristics of a new macromonomer poly(epsilon-caprolactone) with central 4,4'-dicarbaldehyde terphenyl moieties and poly(phenylene vinylene)s with well defined (E-caprolactone), (PPV/PCL) as lateral substituents were investigated via direct pyrolysis mass spectrometry. The unexpectedly high thermal stability of the macromonomer was attributed to intermolecular acetylation of benzaldehyde yielding a hemiacetal and causing a crosslinked structure during the pyrolysis. Increased th...
Thermal degradation of poly(p-phenylene-graft-ε-caprolactone) copolymer
Nur, Yusuf; Yurteri, Seda; Cianga, Ioan; Yagci, Yusuf; Hacaloğlu, Jale (2007-01-01)
The thermal degradation of poly (p-phenylene-graft-epsilon-caprolactone) (PPP), synthesized by Suzuki polycondensation of poly(E-caprolactone) (PCL) with a central 2,5-dibromo-1,4-benzene on the chain with 1,4-phenylene-diboronic acid, has been studied via direct pyrolysis mass spectrometry. The thermal degradation occurred mainly in two steps. In the first step, decomposition of PCL chains occurred. A slight increase in thermal stability of PCL chains was noted. In the second stage of pyrolysis, the decomp...
Thermal degradation of Polylactide/Poly(ethylene glycol) fibers and composite fibers involving organoclay
Ozdemir, Esra; Hacaloğlu, Jale (2018-01-01)
In this study, electrospun fibers of melt blended poly(lactic acid) and poly(ethylene glycol), (PLA)-PEG blends involving 10, 15 and 20 wt% PEG and their corresponding composites with organically modified montmorillonite, Cloisite 30B were prepared and characterized by x-ray diffraction, differential scanning calorimetry, thermogravimetry and direct pyrolysis mass spectrometry techniques. The narrower fiber diameters observed for the PLA-PEG fibers involving organoclay compared to the corresponding neat fib...
Rheological properties of poly(lactic acid) based nanocomposites: Effects of different organoclay modifiers and compatibilizers
Acik, Eda; Orbey, Nese; Yılmazer, Ülkü (2016-01-20)
Poly(lactic acid) (PLA) nanocomposites containing five types of organically modified, layered silicates and two elastomeric compatibilizers, namely ethylene-glycidyl methacrylate (E-GMA) and ethylene-butyl acrylate-maleic anhydride (E-BA-MAH), were prepared using a twin screw extruder. The morphologies of the nanocomposites were determined by X-ray diffraction (XRD) and transmission electron microscopy (TEM), and the rheological properties of the melts were measured using small-amplitude oscillatory shear. ...
High strength bioresorbable bone plates: preparation, mechanical properties and in vitro analysis
Hasırcı, Vasıf Nejat; Bondre, SP; Gresser, JD; Trantolo, DJ; Wise, DL (2000-01-01)
Biodegradable bone plates were prepared as semi-interpenetrating networks (SIPN) of crosslinked polypropylene fumarate (PPF) within a host matrix of either poly(lactide-co-glycolide) - 85 : 15 (PLGA) or poly(l-lactide-co-d,l-lactide) - 70 : 30 (PLA) using N-vinylpyrrolidone (NVP), ethylene glycol dimethacrylate (EGDMA), 2-hydroxyethyl methacrylate (HEMA), and methyl methacrylate (MMA) as crosslinking agents. Hydroxyapatite (HAP), an inorganic filler material, was used to further augment mechanical strength....
Citation Formats
A. Kavas, D. Keskin, K. Altunbas, and A. Tezcaner, “Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells,” INTERNATIONAL JOURNAL OF PHARMACEUTICS, pp. 168–183, 2016, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/41344.